• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A prospective assessment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity.

作者信息

Kirby D F, Wade J B, Mills P R, Sugerman H J, Kellum J M, Zfass A M, Starkey J V, Birkenhauer R, Hamer R M

机构信息

Division of Gastroenterology, Medical College of Virginia Hospitals, Richmond.

出版信息

Am Surg. 1990 Oct;56(10):575-80.

PMID:2221603
Abstract

Morbid obesity is a serious medical hazard, and effective alternatives to surgery have been unsuccessful. In 1985, the Garren-Edwards Gastric Bubble (GEGB) was offered as an adjunct to dietary and behavioral therapy for weight loss treatment. The safety and efficacy of the GEGB were compared with bariatric surgery, the current standard for the treatment of morbid obesity. Fifty-seven patients received GEGB and 77 underwent bariatric surgery. GEGB patients were divided into two groups: those who attended group therapy and those who did not. This study showed that bariatric surgery was far more effective in reducing excess body weight during a 12-month period compared with the GEGB plus group therapy and the GEGB alone. The morbidity from bariatric surgery was greater than in the GEGB-treated groups, while the cost for uncomplicated cases for a year's treatment was comparable. It is concluded that the GEGB does not offer an effective alternative to bariatric surgery in the treatment of morbid obesity.

摘要

相似文献

1
A prospective assessment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity.
Am Surg. 1990 Oct;56(10):575-80.
2
Effects of gastric bubble implant on weight change with and without compliance with a behavior modification program.胃泡植入物对体重变化的影响,以及是否遵守行为改变计划的情况。
Am J Gastroenterol. 1988 Sep;83(9):930-4.
3
A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity.一项关于泰勒胃内气球治疗病态肥胖症的前瞻性多中心临床试验。
Am J Gastroenterol. 1990 Jul;85(7):833-7.
4
Treatment of morbid obesity with intragastric balloon in association with diet.胃内球囊联合饮食治疗病态肥胖症。
Obes Surg. 2002 Aug;12(4):583-7. doi: 10.1381/096089202762252398.
5
Is bariatric surgery necessary after intragastric balloon treatment?胃内球囊治疗后是否需要进行减肥手术?
Obes Surg. 2006 Sep;16(9):1135-7. doi: 10.1381/096089206778392365.
6
Long-term follow-up after gastric surgery for morbid obesity: preoperative weight loss improves the long-term control of morbid obesity after vertical banded gastroplasty.病态肥胖症胃手术后的长期随访:术前体重减轻可改善垂直束带胃成形术后病态肥胖症的长期控制。
Obes Surg. 1999 Oct;9(5):426-32. doi: 10.1381/096089299765552693.
7
Intragastric Balloon胃内球囊
8
BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients.BioEnterics胃内球囊(BIB):一项关于病态肥胖患者体重减轻的短期、双盲、随机、对照、交叉研究。
Int J Obes (Lond). 2006 Jan;30(1):129-33. doi: 10.1038/sj.ijo.0803094.
9
Effect of the Garren-Edwards gastric bubble on gastric emptying.加伦-爱德华兹胃气泡对胃排空的影响。
J Nucl Med. 1989 May;30(5):692-6.
10
The intragastric balloon - smoothing the path to bariatric surgery.胃内球囊——为减肥手术铺平道路。
Obes Surg. 2006 Jul;16(7):897-902. doi: 10.1381/096089206777822188.

引用本文的文献

1
Intra-gastric balloons - The past, present and future.胃内球囊——过去、现在与未来
Ann Med Surg (Lond). 2021 Feb 2;63:102138. doi: 10.1016/j.amsu.2021.01.086. eCollection 2021 Mar.
2
Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes.用于糖尿病患者原发性肥胖治疗的内镜医疗设备
Diabetes Spectr. 2017 Nov;30(4):258-264. doi: 10.2337/ds017-0046.
3
Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method.内镜下胃内球囊植入法治疗病态肥胖症的疗效评估
Wideochir Inne Tech Maloinwazyjne. 2017;12(1):37-48. doi: 10.5114/wiitm.2017.66856. Epub 2017 Mar 30.
4
The Obalon swallowable intragastric balloon in pediatric and adolescent morbid obesity.奥巴隆可吞咽式胃内球囊用于儿童及青少年病态肥胖症。
Endosc Int Open. 2017 Jan;5(1):E59-E63. doi: 10.1055/s-0042-120413.
5
Endoluminal Treatments for Obesity and Related Hypertension: Updates, Review, and Clinical Perspective.腔内治疗肥胖症及相关高血压:更新、综述和临床观点。
Curr Hypertens Rep. 2016 Nov;18(11):79. doi: 10.1007/s11906-016-0691-0.
6
Advances in the Endoscopic Management of Obesity.肥胖症内镜治疗的进展
Gastroenterol Res Pract. 2015;2015:757821. doi: 10.1155/2015/757821. Epub 2015 May 28.
7
Development of minimally invasive techniques for management of medically-complicated obesity.用于治疗伴有内科并发症肥胖症的微创技术的发展
World J Gastroenterol. 2014 Oct 7;20(37):13424-45. doi: 10.3748/wjg.v20.i37.13424.
8
Endoscopic treatment of obesity.肥胖症的内镜治疗
Can J Gastroenterol. 2011 Nov;25(11):627-33. doi: 10.1155/2011/174163.
9
Safety of the Ullorex oral intragastric balloon for the treatment of obesity.用于治疗肥胖症的Ullorex口服胃内球囊的安全性。
J Diabetes Sci Technol. 2007 Jul;1(4):574-81. doi: 10.1177/193229680700100416.
10
Intragastric balloon for obesity.用于治疗肥胖症的胃内气球
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004931. doi: 10.1002/14651858.CD004931.pub2.